Cargando…
Anesthetic Efficacy of Dexmedetomidine versus Midazolam When Combined with Remifentanil for Percutaneous Transluminal Angioplasty in Patients with Peripheral Artery Disease
Anesthesia for percutaneous transluminal angioplasty (PTA) involves a high-risk population having a broad spectrum of pain character and intensity. This study delved the anesthetic efficacy of dexmedetomidine versus midazolam, when used with remifentanil. Seventy patients scheduled for femoropoplite...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518185/ https://www.ncbi.nlm.nih.gov/pubmed/30959941 http://dx.doi.org/10.3390/jcm8040472 |
_version_ | 1783418408347369472 |
---|---|
author | Park, Ji-Hyoung Soh, Sarah Kwak, Young-Lan Kim, Bosung Choi, Sohyun Shim, Jae-Kwang |
author_facet | Park, Ji-Hyoung Soh, Sarah Kwak, Young-Lan Kim, Bosung Choi, Sohyun Shim, Jae-Kwang |
author_sort | Park, Ji-Hyoung |
collection | PubMed |
description | Anesthesia for percutaneous transluminal angioplasty (PTA) involves a high-risk population having a broad spectrum of pain character and intensity. This study delved the anesthetic efficacy of dexmedetomidine versus midazolam, when used with remifentanil. Seventy patients scheduled for femoropopliteal PTA were randomized into two groups receiving either intermittent midazolam boluses (0.03–0.05 mg/kg) (MR group) or dexmedetomidine 0.2–0.7 μg/kg/h after a loading dose of 1.0 μg/kg for 10 min (DR group), both with remifentanil. The primary endpoint was the patients’ satisfaction (1–5, 5; extremely satisfied). Secondary endpoints included postprocedural pain scores (0–10, 10; worst imaginable pain) and adverse events. The satisfaction level of patients was significantly greater in the DR group compared with the MR group (4.0 [3.0, 5.0] versus 4.0 [2.0, 5.0] p = 0.021). The number of patients having a postprocedural pain score of at least 3 was significantly greater in the MR group compared with the DR group (10 [29%] versus 2 [6%], p = 0.013). The number of patients with hypotensive episodes was higher in the DR group (5 [14.7%] versus 0, p = 0.025), which could all be restored with ephedrine. The use of dexmedetomidine in conjunction with remifentanil may be a safe option that provides excellent patient satisfaction while potentially attenuating postprocedural pain. |
format | Online Article Text |
id | pubmed-6518185 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-65181852019-05-31 Anesthetic Efficacy of Dexmedetomidine versus Midazolam When Combined with Remifentanil for Percutaneous Transluminal Angioplasty in Patients with Peripheral Artery Disease Park, Ji-Hyoung Soh, Sarah Kwak, Young-Lan Kim, Bosung Choi, Sohyun Shim, Jae-Kwang J Clin Med Article Anesthesia for percutaneous transluminal angioplasty (PTA) involves a high-risk population having a broad spectrum of pain character and intensity. This study delved the anesthetic efficacy of dexmedetomidine versus midazolam, when used with remifentanil. Seventy patients scheduled for femoropopliteal PTA were randomized into two groups receiving either intermittent midazolam boluses (0.03–0.05 mg/kg) (MR group) or dexmedetomidine 0.2–0.7 μg/kg/h after a loading dose of 1.0 μg/kg for 10 min (DR group), both with remifentanil. The primary endpoint was the patients’ satisfaction (1–5, 5; extremely satisfied). Secondary endpoints included postprocedural pain scores (0–10, 10; worst imaginable pain) and adverse events. The satisfaction level of patients was significantly greater in the DR group compared with the MR group (4.0 [3.0, 5.0] versus 4.0 [2.0, 5.0] p = 0.021). The number of patients having a postprocedural pain score of at least 3 was significantly greater in the MR group compared with the DR group (10 [29%] versus 2 [6%], p = 0.013). The number of patients with hypotensive episodes was higher in the DR group (5 [14.7%] versus 0, p = 0.025), which could all be restored with ephedrine. The use of dexmedetomidine in conjunction with remifentanil may be a safe option that provides excellent patient satisfaction while potentially attenuating postprocedural pain. MDPI 2019-04-06 /pmc/articles/PMC6518185/ /pubmed/30959941 http://dx.doi.org/10.3390/jcm8040472 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Park, Ji-Hyoung Soh, Sarah Kwak, Young-Lan Kim, Bosung Choi, Sohyun Shim, Jae-Kwang Anesthetic Efficacy of Dexmedetomidine versus Midazolam When Combined with Remifentanil for Percutaneous Transluminal Angioplasty in Patients with Peripheral Artery Disease |
title | Anesthetic Efficacy of Dexmedetomidine versus Midazolam When Combined with Remifentanil for Percutaneous Transluminal Angioplasty in Patients with Peripheral Artery Disease |
title_full | Anesthetic Efficacy of Dexmedetomidine versus Midazolam When Combined with Remifentanil for Percutaneous Transluminal Angioplasty in Patients with Peripheral Artery Disease |
title_fullStr | Anesthetic Efficacy of Dexmedetomidine versus Midazolam When Combined with Remifentanil for Percutaneous Transluminal Angioplasty in Patients with Peripheral Artery Disease |
title_full_unstemmed | Anesthetic Efficacy of Dexmedetomidine versus Midazolam When Combined with Remifentanil for Percutaneous Transluminal Angioplasty in Patients with Peripheral Artery Disease |
title_short | Anesthetic Efficacy of Dexmedetomidine versus Midazolam When Combined with Remifentanil for Percutaneous Transluminal Angioplasty in Patients with Peripheral Artery Disease |
title_sort | anesthetic efficacy of dexmedetomidine versus midazolam when combined with remifentanil for percutaneous transluminal angioplasty in patients with peripheral artery disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518185/ https://www.ncbi.nlm.nih.gov/pubmed/30959941 http://dx.doi.org/10.3390/jcm8040472 |
work_keys_str_mv | AT parkjihyoung anestheticefficacyofdexmedetomidineversusmidazolamwhencombinedwithremifentanilforpercutaneoustransluminalangioplastyinpatientswithperipheralarterydisease AT sohsarah anestheticefficacyofdexmedetomidineversusmidazolamwhencombinedwithremifentanilforpercutaneoustransluminalangioplastyinpatientswithperipheralarterydisease AT kwakyounglan anestheticefficacyofdexmedetomidineversusmidazolamwhencombinedwithremifentanilforpercutaneoustransluminalangioplastyinpatientswithperipheralarterydisease AT kimbosung anestheticefficacyofdexmedetomidineversusmidazolamwhencombinedwithremifentanilforpercutaneoustransluminalangioplastyinpatientswithperipheralarterydisease AT choisohyun anestheticefficacyofdexmedetomidineversusmidazolamwhencombinedwithremifentanilforpercutaneoustransluminalangioplastyinpatientswithperipheralarterydisease AT shimjaekwang anestheticefficacyofdexmedetomidineversusmidazolamwhencombinedwithremifentanilforpercutaneoustransluminalangioplastyinpatientswithperipheralarterydisease |